Clinical trial
Radioligand fOr locAl raDiorecurrent proStaTe cancER
NCT05230251 is registered in ClinicalTrials.gov with Glenn Bauman as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Radioligand fOr locAl raDiorecurrent proStaTe cancER
- Lead sponsor
- Glenn Bauman
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- March 17, 2022
- Completion date
- December 31, 2024
- Enrollment
- 3 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
prostate cancer